Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px
Document › Details

Protea Biosciences Group, Inc.. (6/16/14). "Press Release: Protea Announces Advanced Capability to Profile Microbes for Natural Product Chemistry and Metabolite Profiling Research". Morgantown, WV.

Organisations Organisation Protea Biosciences Group Inc.
  Group Protea Biosciences (Group)
  Organisation 2 Gubbs Inc.
Products Product LAESI DP-1000 system
  Product 2 data integration and analysis software (bioinformatics)
Index term Index term Protea Biosciences–Gubbs: data analysis s/w, 201406– supply distribution of Gubbs downstream statistal data analysis s/w with LAESI DP-1000 system
Person Person Kilby, Greg (Protea 201404– Chief Bioanalytics Officer before Thermo Fisher + Agilent + Pfizer)

Protea's LAESI DP-1000 system combined with downstream statistical analyses enables rapid screening of microbial cultures for novel natural product discovery.

Protea Biosciences Group, Inc. (OTCQB: PRGB) announced today the enhanced ability for rapid processing of microbial samples with the LAESI DP-1000 system, coupled with new software that enables the processing of large, complex LAESI-MS data files with downstream statistics programs, provided by Gubbs, Inc.

"Being able to analyze a diverse sample set in well-plate formats creates an immense amount of data contained in one file," stated Dr. Greg Kilby, Protea's Director Molecular Imaging and Bioanalytical Services. Screening for natural products produced by fungi and bacteria can be performed as quickly as 4 seconds per well with the LAESI DP-1000 platform, allowing for rapid screening of samples in standard 96, 384, and 1536 well plates.

"Post processing is necessary, and application of downstream statistics, such as principle component analyses, is essential to rapidly extract biologically relevant information from the volumes of LAESI-MS data generated."

Utilizing the downstream statistical capabilities together with the speed of the LAESI platform without sample preparation empowers researchers to process samples in seconds compared to hours with traditional approaches. Customers will be able to purchase the Gubbs® Software for LAESI Data directly from Protea upon the purchase of a LAESI DP-1000 system.

About Protea Biosciences Group, Inc.

Protea Biosciences (OTCQB:PRGB) is a commercial stage molecular information company, focused on meeting the needs of the pharmaceutical, biotechnology, agriculture, chemical and other industries with innovative bioanalytical technologies,. Protea's proprietary technology, LAESI® (Laser Ablation Electrospray Ionization), is used with mass spectrometry to identify large numbers of distinct molecules from single analyses of tissues, cells, fluids, agricultural specimens and other sample types. Using proprietary software (ProteaPlotTM), the location of each distinct molecule in a respective sample can be displayed, enabling direct molecular imaging. The LAESI DP-1000, an integrated system that combines LAESI and ProteaPlot, is marketed to a wide array of researchers for numerous applications. Protea maintains its own laboratory facility where it performs services using LAESI and complementary technologies for a wide array of customers to support preclinical pharmaceutical R&D, biomarker discovery and other applications.

Forward-Looking Statements

This press release may contain certain statements relating to future results, which are forward looking statements. These statements are not historical facts, but instead represent only the company's belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the company's control. It is possible that the company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the company and its business, including factors that potentially could materially affect the company's financial results, are contained in the company's filings with the Securities and Exchange Commission. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

For more Information:
Protea Biosciences Group, Inc.,
955 Hartman Run Road,
Morgantown, WV 26505 USA
Phone: 304.292.2226
Fax: 304.292.7101

Protea and LAESI are registered trademarks of Protea Biosciences Group, Inc.
Gubbs is a registered trademark of Gubbs, Inc.

Record changed: 2016-03-19


Picture Fairtec GmbH Worldwide Event Solutions 650x65px

More documents for Protea Biosciences (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top